A new analysis published in The Lancet Oncology reveals that the European Union contributes one-sixth of global cancer research funding, totaling €7.4 billion from 2016 to 2023. The US leads with 57% of the funding, while lower-income countries receive minimal investment. The study highlights disparities in research funding, particularly for cancer surgery and radiotherapy, and warns that US funding cuts could exacerbate these inequalities. Teljes cikk (Euronews.com)